Physician profile
Eric Furie
NPI 1245232651
$2,318.28
in general payments reported to CMS, 2019-2025
24 companies · $497 in 2025
The $497 reported for 2025 was more than what 79% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $452 · 2020: $189 · 2021: $185 · 2022: $451 · 2023: $216 · 2024: $329 · 2025: $497.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $560 · Education: $482.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $559.57 |
| Education | $482.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $626.12 | 2020-2025 | Oxford Partial Knee |
| Smith+Nephew, INC. | $340.27 | 2019-2024 | Healicoil, Q-Fix, Bioinductive Implant With Arthroscopic Delivery System - Medium |
| Medtronic, INC. | $258.20 | 2023-2025 | Intellis Adaptivestim |
| Depuy Synthes Sales INC. | $243.97 | 2019-2021 | |
| Nuvasive Specialized Orthopedics, INC. | $126.76 | 2022 | |
| Si-Bone, INC. | $111.81 | 2022 | |
| Next Science LLC | $110.67 | 2021-2022 | |
| Axogen | $77.47 | 2019-2020 | |
| Bioventus LLC | $75.67 | 2019-2021 | |
| Innovation Technologies INC | $59.69 | 2022 | |
| Integra Lifesciences Corporation | $45.91 | 2019-2021 | |
| Amgen INC. | $33.10 | 2024 | Krystexxa |
| Arteriocyte Medical Systems, INC. | $30.29 | 2022 | |
| Boston Scientific Corporation | $22.56 | 2023 | |
| Convatec INC. | $20.50 | 2021 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biocomposites INC | $17.32 | 2021 | |
| Trevena, INC. | $16.82 | 2023 | Olinvyk |
| Sanara Medtech INC. | $16.77 | 2020 | |
| Acelrx Pharmaceuticals, INC. | $16.74 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $16.14 | 2023 | Relistor |
| Osiris Therapeutics INC. | $14.45 | 2019 | |
| Fidia Pharma USA INC. | $12.64 | 2022 | |
| Acumed LLC | $12.60 | 2022 | |
| Ethicon US, LLC | $11.81 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Furie listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.